Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
30 October 2020
Closing Date:
27 November 2020
Location(s):
FRH02 Finistère (FR FRANCE)
Description:
Supply of pharmaceutical specialties for the Finistère health product order group - intermediate relaunch n ° 3

Supply of pharmaceutical specialties for the Finistère health product order group - intermediate relaunch n ° 3.

Trimebutine

Trimebutine.

Midodrine

Midodrine.

Urapidil

Urapidil.

Atovaquone

Atovaquone.

Cinacalcet

Cinacalcet.

Teriparatide

Teriparatide.

Posaconazole

Posaconazole.

Lenalidomide

Lenalidomide.

Sodium oxybate

Sodium oxybate.

Deferiprone

Deferiprone.

Severamer

Sévélamer.

Ascorbic acid (vit. C)

Ascorbic acid (vit. C).

Severamer

Sévélamer.

Calcifediol

Calcifediol.

Dapaglifozin

Dapaglifozin.

Dulaglutide

Dulaglutide.

Iloprost

Iloprost.

Prasugrel

Prasugrel.

Ambrisentan

Ambrisentan.

Flecainide

Flecainide.

Download full details as .pdf
The Buyer:
Centre hospitalier régional et universitaire de Brest
CPV Code(s):
33600000 - Pharmaceutical products